By targeting the metabolic vulnerabilities of CRC cells through the modulation of mitochondrial function and SIRT4 activity, Cnt + C2Cnt could offer promising aid to existing approaches in precision oncology. Here, SIRT4 is linked to colorectal carcinoma.